麻豆传媒

Filters close
Go to Advanced Search
Released: 19-Mar-2025 8:25 PM EDT
Houston Methodist Nurses Help Drive Initiative to Reclassify Penicillin Allergies at the Bedside
Houston Methodist

Houston Methodist nurses help drive initiative to reclassify penicillin allergies at the bedside

Released: 3-Feb-2025 6:00 AM EST
Houston Methodist Researchers Identify Inhibitor Drugs to Treat Aggressive Breast Cancer
Houston Methodist

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

Released: 20-Jan-2025 7:00 PM EST
Houston Methodist Researchers Identify Key Protein to Potentially Halt Autoimmune Diseases and Allergies
Houston Methodist

Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body鈥檚 immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and allergies.

Released: 13-Jan-2025 10:15 AM EST
Leading Cancer Clinician, Researcher Dr. Jenny Chang to Lead Houston Methodist Academic Institute
Houston Methodist

Esteemed cancer clinician-scientist Jenny Chang, M.D., MBBChir, MHCM, has been chosen to lead the Houston Methodist Academic Institute. She will serve as executive vice president, president and CEO, and chief academic officer.

Released: 18-Dec-2024 10:40 PM EST
Houston Methodist Scientists Make Surprising Discovery Pinpointing When Good Cholesterol Becomes Harmful
Houston Methodist

Houston Methodist researchers have discovered that certain components of so-called 鈥済ood鈥 cholesterol -- high-density lipoproteins (HDL) 鈥 may be associated with an increased prevalence of cardiovascular disease.

麻豆传媒: Patient Returns to Houston Methodist 20 Years After Lifesaving Surgery
Released: 27-Nov-2024 12:10 PM EST
Patient Returns to Houston Methodist 20 Years After Lifesaving Surgery
Houston Methodist

More than two decades ago, Mitra Kamali, 4 1/2 months pregnant with twins at age 45, was having lunch with her husband in Houston when out of nowhere she suffered a major seizure.

Released: 1-Nov-2024 4:00 PM EDT
Houston Methodist Researchers Shed Light on Increased Rates of Severe Human Infections Caused by Streptococcus Subspecies
Houston Methodist

A concerning increase in global rates of severe invasive infections becoming resistant to key antibiotics has a team of infectious disease researchers at the Houston Methodist Research Institute studying a recently emerged strain of bacteria called Streptococcus dysgalactiae subspecies equisimilis (SDSE). SDSE infects humans via the skin, throat, gastrointestinal tract and female genital tract to cause infections ranging in severity from strep throat (pharyngitis) to necrotizing fasciitis (flesh-eating disease).

Released: 3-Oct-2024 7:05 PM EDT
Houston Methodist Part of National Consortium to Develop Vaccine Against Herpesviruses
Houston Methodist

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government鈥檚 Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.

Released: 3-Oct-2024 7:05 PM EDT
New Addition to Standard-of-Care Treatments for Non-Small-Cell Lung Cancer Patients Has Potential to Increase Progression-Free Survival
Houston Methodist

Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations could significantly extend progression-free survival for patients with non-small-cell lung cancer (NSCLC), the most common type of lung cancer.

Released: 3-Oct-2024 7:05 PM EDT
Houston Methodist Prepares for Next Pandemic as Part of National NIH-Funded Consortium
Houston Methodist

The question isn鈥檛 if, but when, the next pandemic will hit. Research and observation have identified strong potential for the next pandemic-causing virus to come from one or more of five different virus families.

麻豆传媒: gutmicrobiomeslide-web-size.ashx?mw=1382&hash=7D2FD08137CF7FCFD8BD3433DC214D3D
Released: 18-Sep-2024 4:05 PM EDT
Houston Methodist and Rice University team up to track gut-brain connection
Houston Methodist

For the next two years, 120 Division I Rice University athletes will be part of a concussion study with Houston Methodist researchers to identify reliable and novel concussion biomarkers in their gut microbiomes in ways that standard brain imaging cannot.

麻豆传媒:  Neurology 鈥榟ouse calls鈥 to improve quality of care and life for ALS patients
Released: 18-Jun-2024 2:05 PM EDT
Neurology 鈥榟ouse calls鈥 to improve quality of care and life for ALS patients
Houston Methodist

When second-year neurology resident Dr. Keelie Denson asked her ALS (Amyotrophic Lateral Sclerosis) patients what they found most lacking in ALS care, the answer was easy for Angela Amar. She and her three children, now adults, had been caring for her husband Robert for more than 14 years.

Released: 12-Jun-2024 1:05 PM EDT
Researchers at Houston Methodist find survival improves with open radical hysterectomy in early stage cancer
Houston Methodist

Early-stage cervical cancer patients see better survival and decreased recurrence rates after open radical hysterectomy than minimally invasive laparoscopic approaches, according to a 5-year study led by Houston Methodist researchers and published in the Journal of Clinical Oncology.

麻豆传媒: Researchers at Houston Methodist find difference in pancreatic cancer cells, offering new hope for immunotherapy effectiveness
Released: 30-Apr-2024 5:05 PM EDT
Researchers at Houston Methodist find difference in pancreatic cancer cells, offering new hope for immunotherapy effectiveness
Houston Methodist

A team led by a Houston Methodist physician established a hypothesis that the microenvironments of tumors in the pancreatic head versus the body and tail, particularly the immunotherapy receptors found on each section of the pancreas, differ. This could impact the way cancer of the pancreas is treated.



close
0.13488